Indivior Pharmaceuticals, INC. (INDV) — DEFA14A Filings
All DEFA14A filings from Indivior Pharmaceuticals, INC.. Browse 1 DEFA14A reports with AI-powered summaries and risk analysis.
DEFA14A Filings (1)
-
Indivior Pharmaceuticals Files Definitive Proxy Materials
— Mar 27, 2026 Risk: low
Indivior Pharmaceuticals, Inc. filed a DEFA14A on March 27, 2026, which includes additional definitive proxy soliciting materials. The filing, with SEC Accessio
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX